Overview

Ziprasidone in the Psychosis Prodrome

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This study aims to determine whether ziprasidone is superior to placebo over 24 weeks for patients with the psychosis prodrome.
Phase:
Phase 2
Details
Lead Sponsor:
Yale University
Treatments:
Ziprasidone